As science continues to push the boundaries of medicine, new breakthroughs are changing the way researchers understand some of the world’s deadliest diseases. In the fight against cancer, one of the greatest challenges has been uncovering how tumors interact with the body’s own immune system. Now, a recent development in lung cancer research is offering scientists a deeper look into that relationship, potentially opening the door to more effective treatments and a better understanding of how cancer changes the body from within.
According to VUB Press, a recent study by researchers from the Flemish Institute for Biotechnology and the Free University of Brussels found that the team developed new immune mapping tools to examine how lung adenocarcinoma, the most common type of lung cancer, affects immune cells within tumors. Starting with a mouse model that mirrors human responses and layering in single-cell analysis, researchers traced how tumors shift nearby immune cells’ actions, each step revealing shifts in real time. Professor Damya Laoui from the VIB-VUB Center for Inflammation Research said, “That distinction makes a big difference. It allows us to see much more clearly how immune cells behave and change once they are inside the tumor.”
Skin-based tumor models have long supported early drug testing, yet they miss how lung tissue shapes immune responses. Inside the chest cavity lies an environment that standard methods do not reflect. A research group tackled this by growing lung adenocarcinoma within the organ itself. Instead of placing cells just beneath the skin, they place them where the disease naturally spreads. When matched against actual patient data, the new approach mirrored vital signs of immune activity. This shift reveals what older setups could not show. The body responds differently depending on location, even if the cells look identical. Closer alignment with human biology emerged once tumors developed in their proper setting. Not every lab message captures such nuance. Only after watching cancer evolve deep inside lung tissue did certain patterns become visible.
As stated by Medical News, this study suddenly changed how lung cancer was seen from a medical perspective. A central innovation called SEPARATE-Seq was now created. Inside the body, as in the lungs, immune cells appear in various places: sometimes within the blood vessels, sometimes settled in tissue, at times floating through the airways. Standard single-cell sequencing struggles here, unable to tell which immune cells have actually moved into a tumor versus just passing through the bloodstream; this modernization overcame this limitation by “labelling” immune cells in the blood. Professor Damya Laoui continues by explaining how, “An immune cell inside a blood vessel is not experiencing the same signals as one embedded in tumor tissue. With SEPARATE-Seq, we can finally resolve that difference at single-cell resolution.”
Using SEPERATE-Seq combined with spatial transcriptors, also known as gene expression, scientists pinpointed immune cell types in lung tumors and revealed their precise positions inside the tumor landscape. As reported by Frontiers, the analysis revealed striking patterns within the data, including a fat-loaded border of macrophages surrounding the tumor’s edge and specialized clusters of activated tumor fighters and structural cells. Scientists also discovered increased infiltration of white blood cells, which are building up in the low-oxygen areas of the tumor, and a high concentration of plasma cells, which are another type of immune cell.
With the ongoing progress in research into lung cancer, findings such as the immune mapping tool will have the potential to drastically alter the scientific perspective on the disease. Instead of focusing on how tumors evade immune system attacks, this groundbreaking discovery reveals how cancer actively reprograms immune cells, providing a deeper insight into the intricate interplay between tumors and the immune system. Armed with a better understanding of the mechanisms by which immune cells operate inside tumors, scientists may develop more effective treatments in the future.
